pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›MIFEPRISTONE
drug
save

MIFEPRISTONE

Marketedupdated 3mo ago
by $CORT CORCEPT THERAPEUTICS INC
Approved
community read0 votes

🐶 often sniffed alongside

top 3
  • tagApproval44 co-mentions · 22 sources
  • tagSmall Molecule22 co-mentions · 22 sources
  • companyEvita Solutions LLC1 co-mentions · 1 sources

all catalysts(6)

approval · 6
Apr 11, 2019
approval
7y ago
MIFEPRISTONE — FDA approval
MIFEPRISTONE
→
May 14, 2021
approval
5y ago
MIFEPRISTONE — FDA approval
MIFEPRISTONE
→
Jan 3, 2023
approval
4y ago
MIFEPRISTONE — FDA approval
MIFEPRISTONE
→
Mar 23, 2023
approval
3y ago
MIFEPRISTONE — FDA approval
MIFEPRISTONE
→
Sep 30, 2025
approval
11mo ago
MIFEPRISTONE — FDA approval
MIFEPRISTONE
→
Sep 30, 2025
approval
11mo ago
MIFEPRISTONE — FDA approval
MIFEPRISTONE
→

Trials studying MIFEPRISTONE

  • phase2A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancerrecruitingn=201
  • —Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortionterminatedn=129
  • phase4Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)completedn=1,113
  • phase2RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Traumacompletedn=158
  • phase2REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonismrecruitingn=60
  • phase2Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiencyterminatedn=3

Patent cliff

source: FDA Orange Book
first barrier falls
Aug 27, 2028
~2.0 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (18)

  • Aug 22, 2038method-of-use (U-1643)US 10231983
  • Aug 22, 2038method-of-use (U-1643)US 10314850
  • Aug 22, 2038method-of-use (U-1643)US 10780097
  • Jun 19, 2037method-of-use (U-1643)US 10195214
  • Jun 19, 2037method-of-use (U-1643)US 10842800
  • Jun 19, 2037method-of-use (U-1643)US 11969435
  • Jun 19, 2037method-of-use (U-1643)US 12097210
  • Jan 18, 2037method-of-use (U-1643)US 10151763
  • Aug 15, 2036method-of-use (U-1643)US 9829495
  • Aug 12, 2036method-of-use (U-1643)US 10006924
  • Aug 12, 2036method-of-use (U-1643)US 10495650
  • Apr 20, 2036method-of-use (U-1643)US 10166242
  • Apr 20, 2036method-of-use (U-1643)US 10166243
  • Apr 20, 2036method-of-use (U-1643)US 10660904
  • Apr 20, 2036method-of-use (U-1643)US 9943526
  • Mar 5, 2033method-of-use (U-1643)US 10500216
  • Nov 15, 2032method-of-use (U-1643)US 10842801
  • Aug 27, 2028method-of-use (U-1643)US 89213482.0y

News(10)

  • Virginia federal judge says FDA should reconsider mifepristone restrictions
    At a time when the federal government is evaluating restrictions on medication abortion, a federal judge determined that the last administration imposed too many. A Virginia federal judge ordered t…
    endpoints · 18d ago
  • Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
    A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the abortion pill mifep…
    fiercebiotech · 24d ago
  • A renewed push from the right against abortion pills
    The latest on cyclospora, THC sodas at the grocery store, and more health news from Morning Rounds
    stat · 24d ago
  • STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
    Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug review program
    stat · 2mo ago
  • The latest on Ebola: A travel ban and an old vaccine
    Affordable Care Act changes, drinking while pregnant, and more health news from Morning Rounds
    stat · 2mo ago
  • Texas is opening up a detransition clinic
    Americans exposed to Ebola outbreak, Bill Cassidy's primary defeat, and more health news from Morning Rounds
    stat · 2mo ago
  • Opinion: How to restore credibility to the CDC’s vaccine advisory committee
    Jesse Goodman, former director of CBER and former FDA chief scientist, calls for five critical changes to restore trust in the Advisory Committee on Immunization Practices.
    stat · 2mo ago
  • Opinion: ‘Patient autonomy’ has nothing to do with childhood vaccine policies
    Opinion: Vaccine policy it is not a matter of autonomy at all, because infants do not decline vaccination — their parents do.
    stat · 2mo ago
  • Opinion: The cloudy truth about ‘blue zones’
    “There's been interest in longevity, promoting it, for millennia. But this 25-year campaign really brought it to the forefront,” Eric Topol says of blue zones.
    stat · 3mo ago
  • Opinion: Marty Makary misunderstood something fundamental about the FDA
    “The norm-shattering masks a more fundamental misunderstanding of how administrative power can bring about lasting change,” writes Joshua Sharfstein.
    stat · 3mo ago
view all news mentions →
brand
MIFEPRISTONE
generic
MIFEPRISTONE
indication
Cushing's Syndrome
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 18m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?